Amoytop Biotech offers a comprehensive range of drug products designed to address critical medical needs in the fields of hepatitis treatment and cytokine therapy. Our innovative solutions enhance patient outcomes through advanced biotechnology. These products are developed using cutting-edge research and patented technologies, ensuring high quality and efficacy. From long-acting interferons to advanced cytokine treatments, Amoytop Biotech is committed to providing groundbreaking therapies that challenge the status quo and offer new hope for patients with chronic and acute conditions. Our portfolio includes therapies that target viral hepatitis, enhance immune response, and support hematological health, reflecting our dedication to innovation and excellence in the biotech industry.
Specialized in R&D and production of recombinant protein drugs, and committed to providing better solutions for viral hepatitis, malignant tumor and immunotherapy etc..
